series-c-plus
Stage
2015
Founded
2
Investors
About
Achilles Therapeutics is a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal neoantigens to treat solid tumors.
Explore Achilles Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.